P712-0276 Screening compound: N-(3-fluorophenyl)-2-[8-(3-propyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

P712-0276 Screening compound: N-(3-fluorophenyl)-2-[8-(3-propyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide
P712-0276 Screening compound: N-(3-fluorophenyl)-2-[8-(3-propyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P712-0276
N-(3-fluorophenyl)-2-[8-(3-propyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P712-0276

Molecular Formula

C19H17FN6O2 (C19 H17 FN6 O2)

Compound Name

N-(3-fluorophenyl)-2-[8-(3-propyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

IUPAC name

N-(3-fluorophenyl)-2-[8-(3-propyl-124-oxadiazol-5-yl)-[124]triazolo[43-a]pyridin-3-yl]acetamide

SMILES

CCCc1noc(-c2cccn3c2nnc3CC(Nc2cccc(F)c2)=O)n1

InChI

InChI=1S/C19H17FN6O2/c1-2-5-15-22-19(28-25-15)14-8-4-9-26-16(23-24-18(14)26)11-17(27)21-13-7-3-6-12(20)10-13/h3-4,6-10H,2,5,11H2,1H3,(H,21,27)

InChI Key

DRCZNKGDKTUJAA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613583

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.38

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.450

Distribution Coefficient, logD

2.450

Water Solubility, LogSw

-3.07

Polar Surface Area

78.917

Acid Dissociation Constant (pKa)

10.84

Base Dissociation Constant (pKb)

-2.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

P712-0276 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P712-0276 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P712-0276?
Check Price and Availability of P712-0276, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P712-0276 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P712-0276
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P712-0276
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P712-0276 available by request